Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Genitourinary 3Sarcoma 2Gastrointestinal 2Dermatologic 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1

Conditions

Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

venetoclax 160Cytarabine 117Cyclophosphamide 111Specimen Handling 102Azacitidine 102fludarabine 91Biopsy 78Rituximab 51Methotrexate 45Daunorubicin 45fludarabine phosphate 41Vincristine 38Dexamethasone 37Decitabine 37Injections 36Magnetic Resonance Spectroscopy 35blinatumomab 33Granulocyte Colony-Stimulating Factor 33Mycophenolic Acid 30Idarubicin 30Whole-Body Irradiation 29ibrutinib 28Tacrolimus 27Busulfan 27Prednisone 26Etoposide 26Doxorubicin 26acalabrutinib 24Melphalan 24Filgrastim 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cryosurgery × Other hematologic neoplasm × 90 days × Clear all
NCT03035331 2026-05-04

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Mayo Clinic

Phase 1/2 Completed
11 enrolled 12 charts
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡